Azithromycin for Injection

MARCH 01, 2006

American Pharmaceutical Partners(Schaumburg, Ill) recently received FDA approval for its abbreviated new drug application for Azithromycin for Injection. The product is the generic equivalent of Pfizer Inc's Zithromax. Azithromycin for Injection is indicated for the treatment of community-acquired pneumonia and pelvic inflammatory disease, when caused by susceptible microorganisms. The product will be available in 500-mg vials. Azithromycin for Injection is preservative-free, and each vial will include a bar code and latex-free vial stopper. For more information, visit www.appdrugs.com.




SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.